Comparison of dose rounding and drug vial optimization for reducing anticancer drug waste
- 21 May 2025
- journal article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 32 (7) , 1352-1360
Abstract
Introduction: Numerous injectable anticancer drugs are administered at varying doses based on the body surface area and weight of the patients, often resulting in a certain volume of residual medication. Several anticancer drugs are expensive, thus, their increased use has led to a corresponding increase in drug waste and healthcare costs. Two potential solutions to this issue include drug vial optimization (DVO) and dose rounding (DR). However, DR has rarely been implemented in Japan. Here, we evaluated DVO and DR to assess whether DR could be a viable strategy to reduce the number of anticancer drugs discarded and minimize drug-related costs in Japan. Methods: Patients who received bevacizumab, ramucirumab, gemcitabine, or levofolinate between January and December 2023 at Kanagawa Prefectural Ashigarakami Hospital (Ashigarakami) and Ogaki Municipal Hospital (Ogaki) were included in this study. Actual quantities used for each anticancer drug were extracted from electronic medical records, and the quantities used of drugs during the application of DVO and DR were calculated. Based on these findings, we estimated the reduction in drug waste and the associated cost savings for DVO and DR. Results: DR was more effective than DVO in minimizing the waste of drugs, with 0% waste for gemcitabine at Ogaki and 0% waste for levofolinate at both institutions. Conclusion: Compared with DVO, DR is not influenced by the number of patients treated or the volume of anticancer drugs administered, making it feasible for implementation across a wide range of institutions and a highly effective strategy for minimizing waste. DR should be advocated as a key approach for reducing drug costs in Japan in the future.Keywords
This publication has 11 references indexed in Scilit:
- Reducing Cancer Drug Cost: 3-Year Analysis of Automated Dose Rounding in Electronic Health RecordsJCO Oncology Practice, 2025
- Evaluating cost savings in cytotoxic leftover management: A prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of OncologyJournal of Oncology Pharmacy Practice, 2023
- Determining acceptance and perceptions of chemotherapy dose banding in an ambulatory cancer centreJournal of Oncology Pharmacy Practice, 2023
- Decreasing drug waste, reducing drug costs, and improving workflow efficiency through the implementation of automated chemotherapy dose rounding rules in the electronic health record systemAmerican Journal of Health-System Pharmacy, 2021
- Financial Impact of an Automated Oncology Dose-Rounding Initiative: One-Year AnalysisJCO Clinical Cancer Informatics, 2021
- Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospitalBMC Health Services Research, 2020
- Dose Rounding of Biologic and Cytotoxic Anticancer Agents: A Position Statement of the Hematology/Oncology Pharmacy AssociationJournal of Oncology Practice, 2018
- Potential cost savings associated with dose rounding antineoplastic monoclonal agentsJournal of Oncology Pharmacy Practice, 2014
- Ideal Vial Size for Bortezomib: Real-World Data on Waste and Cost Reduction in Treatment of Multiple Myeloma in BrazilValue in Health, 2011
- Dose Escalation Methods in Phase I Cancer Clinical TrialsJNCI: Journal of the National Cancer Institute, 2009